Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide

Seminars in Nuclear Medicine

Volumn 32, Issue 2, 2002, Pages 92-96

  Menda, Yusuf ^a,b,c   Kahn, Daniel ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEPREOTIDE TC 99M; FLUORODEOXYGLUCOSE; OCTREOTIDE; RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

CANCER SCINTISCANNING; DIAGNOSTIC ACCURACY; FOOD AND DRUG ADMINISTRATION; HUMAN; ISOTOPE LABELING; LUNG NODULE; LUNG NON SMALL CELL CANCER; RECEPTOR AFFINITY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0036223226     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1053/snuc.2002.31564     Document Type: Article

References (13)

1. In vitro detection of somatostatin receptors in human tumors
2. The value of octreotide scintigraphy in patients with lung cancer
3. Gene expression of somatostatin receptor subtypes, SSTR1 and SSTR 2, in human lung cancer cell lines
4. 99mTc-P829
5. Somatostatin receptors and their subtypes in human tumors and peritumoral vessels
6. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides
7. A structure-activity-relationship study of somatostatin receptor-binding peptides radiolabeled with Tc-99m
8. The utility of a somatostatintype receptor binding peptide radiopharmaceutical (P829) in the evaluation of solitary pulmonary nodules
9. 99mTc Depreotide in the evaluation of solitary pulmonary nodules
10. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis
11. A new technique for staging potentially-resectable lung cancer: NeoTect Spect Tc-99m (NeoT) compared with F-18 FDG
12. The utility of NeoTect in the evaluation of pulmonary malignancy
13. 99mTc depreotide (NeoTect™)